Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec;28(13):S299-S301.
doi: 10.3201/eid2813.221175.

Lessons from Nigeria's Adaptation of Global Health Initiatives during the COVID-19 Pandemic

Review

Lessons from Nigeria's Adaptation of Global Health Initiatives during the COVID-19 Pandemic

Chikwe Ihekweazu. Emerg Infect Dis. 2022 Dec.

Abstract

Nigeria receives funds from several global health initiatives that are aimed at addressing elevated risks and overall burden of infectious disease outbreaks. These funds include the Global Fund to Fight AIDS, Tuberculosis and Malaria; US President's Emergency Plan for AIDS Relief; US President's Malaria Initiative; and Global Polio Eradication Initiative. These initiatives have contributed to a substantial reduction in illness and death from HIV, tuberculosis, malaria, and polio. However, Nigeria has experienced mixed success with leveraging the capacities built through these donor-funded vertical programs to respond to new health threats. This report describes experiences using resources from vertical disease programs by the Nigeria Centre for Disease Control in response to the 2014-2016 Ebola outbreak in West Africa and the COVID-19 pandemic. Integrating resources from different disease programs with government-led systems and institutions will improve responses to endemic outbreaks and preparedness for future pandemics in Nigeria.

Keywords: COVID-19; SARS; SARS-CoV-2; coronavirus; coronavirus disease; disease outbreaks; global health; public health; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.

PubMed Disclaimer

Similar articles

  • Leveraging PEPFAR-Supported Health Information Systems for COVID-19 Pandemic Response.
    Mirza M, Grant-Greene Y, Valles MPJS, Joseph P, Juin S, Brice S, Dely P, Clement MGR, Kumar M, Silver M, Wambugu S, Seebregts C, Futerman D, Weissglas F, Muthee V, Blumenthal W, Wuhib T, Yoon S, Rosen DH. Mirza M, et al. Emerg Infect Dis. 2022 Dec;28(13):S49-S58. doi: 10.3201/eid2813.220751. Emerg Infect Dis. 2022. PMID: 36502426 Free PMC article. Review.
  • Use of Project ECHO in Response to COVID-19 in Countries Supported by US President's Emergency Plan for AIDS Relief.
    Wright J, Tison L, Chun H, Gutierrez C, Ning MF, Morales RE, Lopez B, Simpungwe J, Masamaro K, Usmanova N, Mutandi G, Bunga S, Agolory S. Wright J, et al. Emerg Infect Dis. 2022 Dec;28(13):S191-S196. doi: 10.3201/eid2813.220165. Emerg Infect Dis. 2022. PMID: 36502384 Free PMC article. Review.
  • Polio infrastructure strengthened disease outbreak preparedness and response in the WHO African Region.
    Kouadio K, Okeibunor J, Nsubuga P, Mihigo R, Mkanda P. Kouadio K, et al. Vaccine. 2016 Oct 10;34(43):5175-5180. doi: 10.1016/j.vaccine.2016.05.070. Epub 2016 Jul 1. Vaccine. 2016. PMID: 27378681 Review.
  • Leveraging Lessons Learned from Yellow Fever and Polio Immunization Campaigns during COVID-19 Pandemic, Ghana, 2021.
    Amponsa-Achiano K, Frimpong JA, Barradas D, Bandoh DA, Kenu E. Amponsa-Achiano K, et al. Emerg Infect Dis. 2022 Dec;28(13):S232-S237. doi: 10.3201/eid2813.221044. Emerg Infect Dis. 2022. PMID: 36502407 Free PMC article. Review.
  • Effects of COVID-19 Pandemic on Voluntary Medical Male Circumcision Services for HIV Prevention, Sub-Saharan Africa, 2020.
    Peck ME, Ong KS, Lucas T, Prainito A, Thomas AG, Brun A, Kiggundu V, Yansaneh A, Busang L, Kgongwana K, Kelaphile D, Seipone K, Letebele MH, Makadzange PF, Marwiro A, Sesinyi M, Lapidos T, Lukhele N, Maziya V, Mkhontfo M, Gultie T, Mulatu D, Shimelis M, Zegeye T, Teka T, Bulterys M, Njenga JN, Odoyo-June E, Juma AW, Soo L, Talam N, Brown M, Chakare T, Nonyana N, Khoabane MA, Auld AF, Maida A, Msungama W, Kapito M, Nyirenda R, Matchere F, Odek J, Canda M, Malimane I, Come J, Gaspar N, Langa A, Aupokolo MA, Vejorerako KC, Kahindi L, Mali D, Zegeye A, Mangoya D, Zemburuka BL, Bamwesigye J, Kankindi I, Kayirangwa E, Malamba SS, Roels T, Kayonde L, Zimulinda E, Ndengo E, Nsanzimana S, Remera E, Rwibasira GN, Sangwayire B, Semakula M, Rugira E, Rugwizangoga E, Tubane E, Yoboka E, Lawrence J, Loykissoonlal D, Maphothi N, Achut V, Bunga S, Moi M, Amuri M, Kazaura K, Simbeye D, Fida N, Kayange AA, Seleman M, Akao J, Alamo ST, Kabuye G, Kyobutungi S, Makumbi FE, Mudiope P, Nantez B, Chituwo O, Godfrey L, Muyunda B, Kamboyi R, Masiye J, Lifuka E, Mandisarisa J, Mhangara M, Xaba S, Toledo C. Peck ME, et al. Emerg Infect Dis. 2022 Dec;28(13):S262-S269. doi: 10.3201/eid2813.212455. Emerg Infect Dis. 2022. PMID: 36502454 Free PMC article. Review.

Cited by

References

    1. Boutayeb A. The impact of infectious diseases on the development of Africa. In: Preedy VR, Watson RR, editors. Handbook of disease burdens and quality of life measures. New York: Springer; 2010. p. 1171–88.
    1. The Global Fund Office of the Inspector General. Global fund grants in the Federal Republic of Nigeria. Audit Report. 2022. Mar 24 [cited 2022 May 8]. https://www.theglobalfund.org/media/11864/oig_gf-oig-22-003_report_en.pdf
    1. Oyibo W, Ntadom G, Uhomoibhi P, Oresanya O, Ogbulafor N, Ajumobi O, et al. Geographical and temporal variation in reduction of malaria infection among children under 5 years of age throughout Nigeria. BMJ Glob Health. 2021;6:e004250. 10.1136/bmjgh-2020-004250 - DOI - PMC - PubMed
    1. Ekwebelem OC, Nnorom-Dike OV, Aborode AT, Ekwebelem NC, Aleke JC, Ofielu ES. Eradication of wild poliovirus in Nigeria: Lessons learnt. Public Health Pract (Oxf). 2021;2:100144. 10.1016/j.puhip.2021.100144 - DOI - PMC - PubMed
    1. Oteri AJ, Adamu U, Dieng B, Bawa S, Terna N, Nsubuga P, et al. Nigeria experience on the use of polio assets for the 2017/18 measles vaccination campaign follow-up. Vaccine. 2021;39(Suppl 3):C3–11. 10.1016/j.vaccine.2021.04.040 - DOI - PubMed

MeSH terms